Dr. William (Bill) S. Dalton is Founder and Executive Chair of M2Gen, a national biotechnology subsidiary of the Moffitt Cancer Center.  He is the past President, CEO & Center Director of Moffitt Cancer Center, an NCI-Designated Comprehensive Cancer Center (2002-2012). Prior to joining Moffitt, Dr. Dalton was the Dean of the University of Arizona College of Medicine.  His research interests include development of information systems to allow aggregation, organization, and sharing of patient data in real time to enhance discovery and delivery of evidenced-based precision medicine.  For his leadership in the area of personalized medicine, Dr. Dalton was recognized as the 2010 recipient of the Personalized Medicine Coalition’s National Leadership in Personalized Medicine Award. Dr. Dalton’s basic and translational research interests focus on molecular mechanisms of drug resistance and drug discovery.  He has over 200 publications, serves on several editorial boards, and has numerous patents in the fields of drug discovery and computer/information networking.  He has served on numerous not-for-profit boards, including the National Board of the Leukemia and Lymphoma Society; he is the past-Chair of the Personalized Medicine Coalition and is the current Board Chair of the Institute of Human and Machine Cognition. He is also the past-President of the Association of American Cancer Institutes.